Scientists, Publishers Debate Paychecks for Peer Reviewers
Scientists, Publishers Debate Paychecks for Peer Reviewers
While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.
Scientists, Publishers Debate Paychecks for Peer Reviewers
Scientists, Publishers Debate Paychecks for Peer Reviewers

While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

research integrity
UPDATED
Physician Behind Surgisphere Scandal Switches Medical Licenses
Physician Behind Surgisphere Scandal Switches Medical Licenses
Catherine Offord | Oct 23, 2020
Sapan Desai has inactivated his license in Illinois, where multiple malpractice lawsuits against him are pending, and obtained a new one in Ohio.
<em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
Italian Institute Revokes Appointment of Cancer Researcher
Italian Institute Revokes Appointment of Cancer Researcher
Catherine Offord | Jul 7, 2020
Pier Paolo Pandolfi left Harvard University last year following allegations of sexual harassment, and has since been accused of research misconduct.
Opinion: Don&rsquo;t Disparage the Pace of COVID-19 Research
Opinion: Don’t Disparage the Pace of COVID-19 Research
John D. Loike, Salomon Amar | Jun 22, 2020
Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.
Special Report
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Catherine Offord | Jun 16, 2020
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.
Opinion: Surgisphere Fiasco Highlights Need for Proper QA
Opinion: Surgisphere Fiasco Highlights Need for Proper QA
Nadya Gawadi Heywood, David Long | Jun 12, 2020
Our handbook on best practices for quality assurance in biomedicine can help funding agencies shore up research integrity—which is especially needed at a time when mistakes can have outsize effects.
Surgisphere Fallout Hits African Nonprofit&rsquo;s COVID-19 Efforts
Surgisphere Fallout Hits African Nonprofit’s COVID-19 Efforts
Catherine Offord | Jun 7, 2020
The company had helped develop a tool to aid decision-making in distributing limited medical equipment among coronavirus patients, but two high-profile retractions call into question the validity of Surgisphere’s work in toto.
<em>Lancet, NEJM </em>Retract Surgisphere Studies on COVID-19 Patients
Lancet, NEJM Retract Surgisphere Studies on COVID-19 Patients
Catherine Offord | Jun 4, 2020
All authors other than company founder and CEO Sapan Desai were “unable to complete an independent audit of the data,” The Lancet states.
Concerns Build Over Surgisphere&rsquo;s COVID-19 Dataset
Concerns Build Over Surgisphere’s COVID-19 Dataset
Catherine Offord | Jun 2, 2020
NEJM and The Lancet issue expressions of concern as researchers question where the company got its data on thousands of coronavirus patients.